cho_logo_symbol_border

Latest News

The Dangers of Growing False Negative Rates

How shortfalls of the current COVID test market affect us personally and globally April 15, 2022 On January 8th, 2021 the FDA Released a Statement that “false negative results may occur with any molecular test for the detection of SARS-CoV-2 if a mutation occurs in the

Read More

The Pandemic Is NOT Over

Based on multiple complicating factors we may be heading into a tsunami sized wave of new COVID cases

Read More

Omicron

What You Need to Know:  Omicron (B.1.1.529) South African Variant  Clear Health Pass Covid Pandemic Update: December 06, 2022   The B.1.1.529 variant was first reported to the World Health Organization (WHO) from South Africa on November 24, 2021. The epidemiological situation in South Africa has

Read More

Study: Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review

It is unclear whether more timely cancer diagnosis brings favourable outcomes, with much of the previous evidence, in some cancers, being equivocal. We set out to determine whether there is an association between time to diagnosis, treatment and clinical outcomes, across all cancers for symptomatic presentations.

Read More

Study: Non-Classical monocytes display inflammatory features: Validation in Sepsis and Systemic Lupus Erythematous

Monocytes are a group of immune cells that originate in bone marrow and are released into peripheral blood, where they circulate for several days1,2. They belong to the mononuclear-phagocyte system, which also include macrophages, dendritic cells and their bone-marrow precursors3,4,5. Monocytes represent 5–10% of peripheral leucocytes

Read More

Study: CD16 is indispensable for antibody-dependent cellular cytotoxicity by human monocytes

Immunoglobulin G (IgG) antibody subclasses play major roles in the control of bacterial and viral infections, the killing of tumour cells during antibody therapy and the pathological destruction of healthy tissues in autoimmune diseases. As a result of their potency and range of actions, antibodies have

Read More

Study: Frequent neurologic manifestations and encephalopathy-associated morbidity in Covid-19 patients

Covid-19 can involve multiple organs including the nervous system. We sought to characterize the neurologic manifestations, their risk factors, and associated outcomes in hospitalized patients with Covid-19.

Read More

Study: Optical Biosensors for Virus Detection: Prospects for SARS-CoV-2/COVID-19

Optical biosensors have led to significant advancements in virus detection and imaging capabilities. Coupled with advanced instrumentation, they have enabled higher sensitivities while increasing the rate at which samples can be tested. These techniques can be developed into point-of-care (POC) diagnostics for viral detection and are

Read More

Study: SARS-CoV-2 Transmission From People Without COVID-19 Symptoms

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the etiology of coronavirus disease 2019 (COVID-19), is readily transmitted person to person. Optimal control of COVID-19 depends on directing resources and health messaging to mitigation efforts that are most likely to prevent transmission, but the relative importance of

Read More

Study: Comparative evaluation of 19 reverse transcription loop-mediated isothermal amplification assays for detection of SARS-CoV-2

Coronavirus disease 2019 (COVID-19) caused by SARS-CoV-2 has caused a global pandemics. To facilitate the detection of SARS-CoV-2 infection, various RT-LAMP assays using 19 sets of primers had been developed, but never been compared. 

Read More

 

Our Journey to $1B+ Valuation

 

Disrupting Healthcare Testing / Diagnostics Early Detection of Cancer,
Chronic Conditions, Disease, Unlocking Anti-Aging Genomics & Promoting Longevity.

 

FUNDING GOAL $5,000,000

Funding Goal $5,000,000

20%

Skip to content